Eko Analysis Software vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Devices
VS
by Carewell Health

AI Verdict

Tool A, Eko Analysis Software, focuses on early detection of heart murmurs and atrial fibrillation by integrating AI with digital stethoscopes for point-of-care and remote monitoring. In contrast, Tool B, AI-ECG Tracker, provides comprehensive AI-powered auto-analysis and diagnosis for a wide range of cardiac abnormalities based on 12-lead ECG data. While both are FDA-cleared cardiology AI tools, they address different data inputs and specific diagnostic scopes within cardiac assessment.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you require an FDA-cleared, AI-powered solution for early detection of heart murmurs and atrial fibrillation during routine physical exams or telehealth consultations. Its cloud-based platform and wireless auscultation capabilities make it ideal for remote monitoring and quick, proactive cardiovascular screening.

View Eko Analysis Software →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your practice demands rapid, highly accurate, and comprehensive AI-powered diagnosis of 12-lead ECGs for a wide array of cardiac abnormalities, including arrhythmias, myocardial ischemia, and infarction. Its on-premise workstation with powerful GPU is well-suited for high-volume clinical settings requiring detailed and swift ECG interpretation.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software AI-ECG Tracker
Pricing Freemium with subscription for full features Unknown
Deployment Cloud-based Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software, with its integration into a mobile app and digital stethoscopes, offers a more streamlined and accessible point-of-care experience. Its cloud-based deployment further enhances ease of use and accessibility compared to Tool B's on-premise workstation and Windows client.

Clinical Value

AI-ECG Tracker

While both are FDA-cleared and provide significant clinical value, AI-ECG Tracker offers a broader and deeper diagnostic capability by analyzing 12-lead ECG data for a comprehensive range of 104 ECG diagnostic classifications, including critical conditions like myocardial ischemia and infarction. Eko's focus is more on early detection of murmurs and AFib via stethoscope-integrated ECG.

Pricing & Value

Eko Analysis Software

Eko Analysis Software's freemium model with transparent subscription tiers allows users to assess its basic features before committing to a paid plan, offering clear value and flexibility. The lack of publicly available pricing for AI-ECG Tracker makes it difficult for potential customers to evaluate its cost-effectiveness upfront.

Enterprise Readiness

AI-ECG Tracker

AI-ECG Tracker's offering of both on-premise deployment with a powerful workstation and a web-based management portal for organization settings, security, and task management demonstrates a more comprehensive suite of features for enterprise-level control and integration. While Eko also supports enterprises, Tool B's deployment flexibility and explicit management features give it an edge.

Innovation

Eko Analysis Software

Eko Analysis Software demonstrates greater innovation by integrating AI directly into the ubiquitous stethoscope and mobile app, transforming a traditional physical exam tool into a smart diagnostic aid for early, point-of-care detection. This approach offers a more disruptive and accessible innovation compared to the advanced but more conventional AI-driven 12-lead ECG analysis of Tool B.

Support & Docs

Eko Analysis Software

Eko Analysis Software provides a more explicitly detailed and organized support ecosystem, including dedicated help centers for different user types, readily available user manuals, and various direct contact methods. While Tool B's company offers general support, Eko's commitment to comprehensive and accessible product-specific support is more evident.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software AI-ECG Tracker
Name Eko Analysis Software AI-ECG Tracker
Company Eko Devices Shenzhen Carewell Electronics Co.
Primary AI Functionality / Key Detections FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm, Calculation of cardiac time intervals (heart rate, QRS duration). AI-powered ECG auto-analysis and diagnosis with high accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; Comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications.
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Emergency Medicine
Data Storage / Management Secure cloud-based storage of recordings within the US. Web-based Management Portal for organization settings, security, and task management; Window-based professional ECG diagnostic client for review, measurement, annotation, and report generation.

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is FDA-cleared to assist in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation (AFib), and also detects normal sinus rhythm and calculates cardiac time intervals. AI-ECG Tracker offers comprehensive AI-powered ECG auto-analysis and diagnosis for a wide range of cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, covering 16 cardiac classifications and 104 ECG diagnostic classifications.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app for wireless auscultation and ECG recordings. AI-ECG Tracker supports 12-lead ECG data collection, utilizing an AI-ECG Workstation for analysis.
Eko Analysis Software is FDA-cleared for its AI-powered detection capabilities for heart murmurs and atrial fibrillation. AI-ECG Tracker boasts a high accuracy rate of over 95% for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Eko Analysis Software is designed for Cardiology, Emergency Medicine, and Internal Medicine. AI-ECG Tracker is primarily focused on Cardiology and Emergency Medicine.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.